INS and hyperprolactinemia: In the present study, bromocriptine, which is well known to effectively reduce hyperprolactinemia [36, 37], was administered daily just after the time of day of the normal circadian peak in plasma prolactin levels in lean, insulin sensitive rats [31] prior to the end of the photoperiod to re-establish the normal dopaminergic circadian input activity to the SCN.